Tested Applications
| Positive WB detected in | HepG2 cells, COLO 320 cells, HeLa cells, MCF-7 cells |
| Positive IF/ICC detected in | HeLa cells |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
21778-1-AP targets POLA2 in WB, IHC, IF/ICC, ELISA applications and shows reactivity with human samples.
| Tested Reactivity | human |
| Cited Reactivity | human |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag0271 Product name: Recombinant human POLA2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 17-275 aa of BC001347 Sequence: LDCEEALIEKLVELCVQYGQNEEGMVGELIAFCTSTHKVGLTSEILNSFEHEFLSKRLSKARHSTCKDSGHAGARDIVSIQELIEVEEEEEILLNSYTTPSKGSQKRAISTPETPLTKRSVSTRSPHQLLSPSSFSPSATPSQKYNSRSNRGEVVTSFGLAQGVSWSGRGGAGNISLKVLGCPEALTGSYKSMFQKLPDIREVLTCKIEELGSELKEHYKIEAFTPLLAPAQEPVTLLGQIGCDSNGKLNNKSVILEGD Predict reactive species |
| Full Name | polymerase (DNA directed), alpha 2 (70kD subunit) |
| Calculated Molecular Weight | 70 kDa |
| Observed Molecular Weight | 68-70 kDa |
| GenBank Accession Number | BC001347 |
| Gene Symbol | POLA2 |
| Gene ID (NCBI) | 23649 |
| RRID | AB_10733243 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q14181 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IF protocol for POLA2 antibody 21778-1-AP | Download protocol |
| WB protocol for POLA2 antibody 21778-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The POLA2 Polyclonal antibody (Cat# 21778-1-AP) has 3 citations published in Nucleic Acids Research, Cancer Cell International, and Translational Cancer Research. The cited applications include Western blot and IHC in human samples. Research fields span telomerase biology and hepatocellular carcinoma, with studies examining POLA2 overexpression in immune infiltration and E2F-mediated upregulation correlated with macrophage infiltration and poor prognosis.
| Species | Application | Title |
|---|---|---|
Nucleic Acids Res CST does not evict elongating telomerase but prevents initiation by ssDNA binding. | ||
Cancer Cell Int Overexpression of POLA2 in hepatocellular carcinoma is involved in immune infiltration and predicts a poor prognosis | ||
Transl Cancer Res E2F-mediated POLA2 upregulation is correlated with macrophage infiltration and poor prognosis in hepatocellular carcinoma |

















